Susquehanna International Group, LLP Delcath Systems, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 75,415 shares of DCTH stock, worth $730,771. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,415
Previous 33,362
126.05%
Holding current value
$730,771
Previous $279,000
143.73%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding DCTH
# of Institutions
73Shares Held
7.62MCall Options Held
198KPut Options Held
41.7K-
Aigh Capital Management LLC Baltimore, MD1.78MShares$17.3 Million6.51% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.11MShares$10.8 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA997KShares$9.66 Million1.32% of portfolio
-
Essex Investment Management CO LLC Boston, MA337KShares$3.26 Million0.57% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny312KShares$3.02 Million0.0% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $83.3M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...